Cargando…

Proteogenomic characterization of cholangiocarcinoma

Cholangiocarcinoma (CCA) is a highly heterogeneous cancer with limited understanding and few effective therapeutic approaches. We aimed at providing a proteogenomic CCA characterization to inform biological processes and treatment vulnerabilities. APPROACH AND RESULTS: Integrative genomic analysis w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Mengjie, Ran, Peng, Chen, Lingli, Wang, Yunzhi, Yu, Zixiang, Cai, Ke, Feng, Jinwen, Qin, Zhaoyu, Yin, Yanan, Tan, Subei, Liu, Yang, Xu, Chen, Shi, Guoming, Ji, Yuan, Zhao, Jian‐Yuan, Zhou, Jian, Fan, Jia, Hou, Yingyong, Ding, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles: Liver Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869950/ https://www.ncbi.nlm.nih.gov/pubmed/35716043 http://dx.doi.org/10.1002/hep.32624

Ejemplares similares

Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
por: Wang, Yunzhi, et al.
Publicado: (2023)

Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes
por: Li, Lingling, et al.
Publicado: (2023)

Integrative proteogenomic characterization of early esophageal cancer
por: Li, Lingling, et al.
Publicado: (2023)

Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021)

Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ
por: Yao, Zhenmei, et al.
Publicado: (2023)

Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021)

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
por: Tong, Yexin, et al.
Publicado: (2022)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01
por: Jarman, Edward J., et al.
Publicado: (2022)

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors
por: Zhang, Fan, et al.
Publicado: (2022)

Multicentre, phase II study of gemcitabine and S‐1 in patients with advanced biliary tract cancer: TG1308 study
por: Chiang, Nai‐Jung, et al.
Publicado: (2020)

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
por: Park, Joong-Won, et al.
Publicado: (2015)

Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma
por: Gao, Xu-dong, et al.
Publicado: (2014)

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Cholangiocarcinoma arising in von Meyenburg complexes
por: Kim, Hee Kyung, et al.
Publicado: (2011)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Intrahepatic cholangiocarcinoma arising in Caroli's disease
por: Jang, Min Hye, et al.
Publicado: (2014)

A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2022)

A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resection
por: Klompenhouwer, Anne J., et al.
Publicado: (2020)

Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma
por: Paur, Jakob, et al.
Publicado: (2020)

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
por: Labeur, Tim A., et al.
Publicado: (2019)

Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma
por: Prawira, Aldo, et al.
Publicado: (2020)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
por: Reig, Maria, et al.
Publicado: (2020)

Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligence
por: Giordano, Silvia, et al.
Publicado: (2020)

Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course
por: van Rosmalen, Belle V., et al.
Publicado: (2021)

Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
por: Li, Chenxi, et al.
Publicado: (2022)

Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study
por: Muñoz‐Martínez, Sergio, et al.
Publicado: (2022)

Alcohol‐related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis
por: Costentin, Charlotte E., et al.
Publicado: (2022)

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2022)

Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern
por: Choe, Ji-Young, et al.
Publicado: (2014)

Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis
por: Kim, Ah Yeong, et al.
Publicado: (2016)

Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report
por: Kim, Hye Min, et al.
Publicado: (2015)

Liver Transplantation for Cholangiocarcinoma: Charting a Path With Lessons Learned From Center Experience
por: Ziogas, Ioannis A., et al.
Publicado: (2021)

Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
por: Lee, Kyoung-Bun
Publicado: (2016)

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation
por: Shiode, Yuto, et al.
Publicado: (2023)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions
por: Hughes, Neill R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s5d77bb7f447emu04rte2glsac